Filing Details
- Accession Number:
- 0001110803-14-000112
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-11 19:57:44
- Reporting Period:
- 2014-03-11
- Filing Date:
- 2014-03-11
- Accepted Time:
- 2014-03-11 19:57:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1263805 | O Christian Henry | 5200 Illumina Way San Diego CA 92122 | Svp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-03-11 | 3,000 | $28.45 | 31,519 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-03-11 | 700 | $166.12 | 30,819 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-03-11 | 1,300 | $167.08 | 29,519 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-03-11 | 900 | $167.89 | 28,619 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-03-11 | 100 | $168.86 | 28,519 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-03-11 | 3,000 | $0.00 | 3,000 | $28.45 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2009-02-28 | 2019-01-28 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sales price representing 700 shares sold ranging from $165.70 to $166.36 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sales price representing 1,300 shares sold ranging from $166.71 to $167.60 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sales price representing 900 shares sold ranging from $167.71 to $168.37 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.